News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
PCI and the Philadelphia Alliance for Capital and Technologies (PACT) jointly presented a recent event called “AI Nexus: Shaping Tomorrow’s Intelligence."
César de la Fuente, PhD, Presidential Assistant Professor at Penn, has significantly advanced the field of antibiotic discovery through his innovative use of computational and AI-assisted techniques.
Davis' relatively benign symptomology is attributed to low levels of the inflammatory protein MMP-9, which seems to prevent the characteristic abnormal bone formation.
This device, whose heat tolerance far surpasses existing commercial storage technologies, could help to facilitate computing under extreme conditions like deep-earth drilling and space missions.
The platform, called Jochi, which has further evolved since its conception in 2020, integrates easily into existing school systems and provides educators with tools to support these students.
Penn Medicine researchers have developed an mRNA vaccine for the H5N1 avian flu using techniques similar to those enabling mRNA-based COVID-19 vaccines.
The European Commission has approved Sobi's drug Aspaveli® (pegcetacoplan) for broader use in adults with paroxysmal nocturnal hemoglobinuria (PNH), a rare blood disorder.
Measur plans to bring Exyn's cutting-edge technologies like the Nexys 3D SLAM LiDAR payload system to market.
This new site will support the production of Cogwear’s second-generation brain-tracking headband, which offers real-time insights into various brain functions.
By electroplating specialized magnetic alloys directly onto semiconductor substrates, EnaChip offers innovative, high-performance, and cost-effective magnetic solutions.